The presence of macrophages and Th2-polarized CD4+ T cells limits the efficacy of radiotherapy for breast cancer, and eliminating these cells or neutralizing IL-4 may improve the clinical response to cytotoxic therapy in breast cancer patients [130]. Here, IL4 is linked to breast cancer.